NR3C2 and colitis: We report here that the anti-inflammatory potential of Naticol®Gut during colitis is mediated by the mannose receptor (MR) on macrophages as in mice with MR-deficient macrophages, Naticol®Gut treatment loses its ability to attenuate colitis and to orient macrophages toward an anti-inflammatory phenotype.